23948sdkhjf
Log in or create to bookmark articles
Get access to all content on Life Science Focus
No commitment or card information required
Applies to personal subscription only.
Contact us for a enterprise solution.
Advertisement
Advertisement

Inossia raises SEK 88m – targets US approval

The Swedish medtech company Inossia, which is developing an additive for bone cement, has completed an oversubscribed SEK 88 million share issue.
Advertisement

The fundraising comprises a rights issue for existing shareholders and a directed share issue to a select group of investors. The latter was subscribed to primarily by the EIC Fund and Cradle Growth, a relatively new Nordic growth equity and venture capital firm that has also invested in companies such as Suturion and Cuviva.

Advertisement Advertisement
BREAKING
{{ article.headline }}
0.048|